FDAMA Pediatric Incentives Should Apply To Biologics, PhRMA Testifies
Executive Summary
FDA may be willing to discuss new incentives for manufacturers to conduct pediatric studies on products not covered under the FDA Modernization Act's pediatric exclusivity rule, FDA Commissioner Henney said Oct. 21 at a hearing of the Senate Health, Education, Labor & Pensions Committee.
You may also be interested in...
Senate Hearings On IoM Medical Errors Report Planned For Early 2000
Senate Labor/HHS Appropriations Subcommittee Chairman Specter (R-Penn.) is planning a hearing to discuss recommendations outlined in a Nov. 29 Institute of Medicine report on medical errors and patient safety.
Senate Hearings On IoM Medical Errors Report Planned For Early 2000
Senate Labor/HHS Appropriations Subcommittee Chairman Specter (R-Penn.) is planning a hearing to discuss recommendations outlined in a Nov. 29 Institute of Medicine report on medical errors and patient safety.
Epogen Pediatric Use & Neupogen Cable Ads Expand Major Amgen Franchises
New cable TV ads to identify new cancer patients for Neupogen and a recently approved expansion of Epogen indications to the pediatric population are examples of Amgen's increasing efforts to support its flagship franchises.